Price M R
Cancer Research Campaign Laboratories, University of Nottingham, University Park, UK.
Br J Cancer. 1988 Feb;57(2):165-9. doi: 10.1038/bjc.1988.34.
Of 15 anti-CEA monoclonal antibodies, the first 8 were reactive only with CEA, while the remaining 7 antibodies reacted with epitopes commonly expressed on CEA and the normal cross-reacting antigen, NCA. Separate and distinct, conformation-dependent (i.e. susceptible to reduction and alkylation), CEA-associated epitopes were identified using antibodies 1, 2 and 3. Antibodies 4 to 7 defined a series of conformation-independent epitopes which were topographically closely related on the CEA molecule. Antibody number 8 reacted with a separate determinant found on CEA but not NCA, and this also was resistant to reduction and alkylation. Antibody number 9 defined an epitope which was commonly expressed on CEA and NCA. This epitope was conformation-dependent and was the most sensitive to NaIO4. The remaining antibodies, 10 to 15, which also reacted with CEA and NCA, defined an immunodominant region of these molecules since the 6 epitopes were clearly closely related, but not necessarily identical. The findings presented establish a rational basis for the selection of combinations of anti-CEA antibodies for diagnostic and therapeutic purposes.
在15种抗癌胚抗原(CEA)单克隆抗体中,前8种仅与CEA发生反应,而其余7种抗体则与CEA和正常交叉反应抗原NCA上共同表达的表位发生反应。使用抗体1、2和3鉴定出了单独且不同的、依赖构象的(即对还原和烷基化敏感的)CEA相关表位。抗体4至7定义了一系列在CEA分子上拓扑结构紧密相关的不依赖构象的表位。抗体8与在CEA上发现但不在NCA上的一个单独决定簇发生反应,并且该决定簇也对还原和烷基化具有抗性。抗体9定义了一个在CEA和NCA上共同表达的表位。该表位依赖构象,并且对高碘酸钠最为敏感。其余抗体10至15也与CEA和NCA发生反应,它们定义了这些分子的一个免疫显性区域,因为这6个表位明显紧密相关,但不一定相同。所呈现的研究结果为选择用于诊断和治疗目的的抗CEA抗体组合奠定了合理基础。